IHG Genotech Symposium September 22, 2025 Agenda
Time | Who | Title | Talk Title | |
Introductions | 9:00-9:05 | Talmadge E. King Jr., MD | Dean, School of Medicine, UCSF Vice Chancellor, Medical Affairs, UCSF Health | |
9:05-9:15 | Nadav Ahituv, PhD | Director, Institute for Human Genetics, UCSF | ||
Gene Therapy | 9:15-9:35 | Jacob Kimmel, PhD | Co-founder & President, NewLimit | Restoring youthful function with reprogramming therapies |
9:35-9:55 | Dan Hart, PhD | Head of Platform, Epicrispr Biotechnologies | EPIC GEMS: An Epigenetic Editing Platform for In vivo Therapeutic Applications | |
9:55-10:25 | Paul Donohoue | Director of Platform Discovery, Caribou Biosciences | A versatile CRISPR hybrid RNA-DNA editing technology for the generation of off-the-shelf cell therapies | |
10:25-10:45 | Chris Hsiung, MD, PhD | Assistant Professor, Institute for Human Genetics and Dept. of Surgery, UCSF | Higher-order combinatorial functional genomics | |
10:45-11:15 | Panel Discussion | |||
Break | 11:15-11:45 | |||
Keynote Speaker | 11:45-12:30 | Michael Snyder, PhD | Stanford W. Ascherman Professor of Genetics, Stanford University | The Genetic Basis of Complex Diseases Revealed Using AI methods |
Lunch & Career Panel | 12:30-1:45 | KT Moortgat, PhD
Shishi Luo, PhD
Mike Schnall-Levin, PhD
Michael Snyder, PhD | Founder, Managing Partner, Dalena Capital Director of Bioinformatics, Helix Chief Technology Officer, Founding Scientist, 10X Genomics Stanford W. Ascherman Professor of Genetics, Stanford University |
|
AI | 1:45-2:05 | Kyle Farh, MD, PhD | VP & Distinguished Scientist, Illumina Artificial Intelligence Lab | |
2:05-2:25 | Shishi Luo, PhD | Director of Bioinformatics, Helix | Precision Medicine: From Exome Data to Drug Response with a Little Help from LLMs | |
2:25-2:45 | Xiao Yang, PhD | Co-founder & CEO, PromptBio | PromptBio: A Multi-Agent AI Platform for Bioinformatics Data Analysis | |
2:45-3:05 | Jeff Spence, PhD | Assistant Professor, Department of Epidemiology & Biostatistics, UCSF | Accurate estimation of gene constraint by combining interpretable models and machine learning | |
3:05-3:25 | Panel Discussion | |||
Break | 3:25-3:55 | |||
Genomic Technologies | 3:55-4:15 | Kathleen Barnes, PhD | SVP Population & Precision Health, Oxford Nanopore | |
4:15-4:35 | Mike Schnall-Levin, PhD | Chief Technology Officer, Founding Scientist, 10X Genomics | Driving the Next Level of Scale of Single Cell and Spatial | |
4:35-4:55 | Matthew Kellinger, PhD | VP of Biochemistry & Co-founder, Element Biosciences | ||
4:55-5:15 | Diego Calderon, PhD | Assistant Professor, Department of Bioengineering and Therapeutic Sciences, UCSF | The continuum of gene regulation at single-cell resolution, from Drosophilia development to human complex traits | |
5:15-5:45 | Panel Discussion | |||
Reception | 6:00-7:00 |